| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.27 | 0.06 |